Did you know that osteoarthritis affects approximately 528 million people worldwide? The knee is the most commonly impacted joint in this degenerative condition, which can severely limit mobility and quality of life. Recent advances in rheumatology suggest that osteoarthritis may be managed—and even somewhat reversed—through injectable treatments like hyaluronic acid.
For those seeking innovative, non-surgical solutions, Supartz and Synvisc offer viscosupplement treatments. These injections replicate the properties of healthy synovial fluid, providing symptomatic relief to the affected knee joint. Understanding the differences in their characteristics can help providers and patients decide which treatment to maximize.
This article will compare Supartz vs Synvisc, their active ingredients, administration protocols, clinical effectiveness, and patient experiences addressing knee OA.
Key Takeaways
- Viscosupplement entails injecting a hyaluronic acid solution into the affected knee joint, providing symptomatic relief for patients with knee osteoarthritis.
- Supartz and Synvisc have similar active ingredients in hyaluronic acid (HA) but differ in their source and composition of HA.
- Supartz requires three to five weekly injections. Conversely, Synvisc typically involves either three weekly injections or a single Synvisc-One injection.
- Consulting a healthcare professional ensures a treatment plan tailored to individual health needs and potential contraindications.
About: Medica Depot is your trusted all-in-one supplier, offering a range of high-quality medical injectables and supplies. Buy Supartz online at Medica Depot today! Whether for health professionals, plastic surgeons, dermatologists, licensed estheticians, or other specialists, we can offer genuine, brand-name products you may need. With Medica Depot, we prioritize serving you better to improve the patient’s quality of life.
Understanding Viscosupplements
Knee osteoarthritis (OA) is a leading cause of disability in the United States, characterized by cartilage breakdown that results in joint pain, inflammation, and restricted mobility. While there is currently no cure, one promising treatment is viscosupplementation.
Viscosupplements are injectable treatments containing hyaluronic acid (HA), a substance naturally found in joint fluid. This approach involves injecting HA directly into the knee joint to relieve OA symptoms, particularly in patients who haven’t responded to first-line therapies. By restoring the synovial fluid’s natural viscoelastic properties, viscosupplements act as a lubricant and cushion within the joint.
The result is reduced pain and inflammation and improved knee function, offering an effective option to alleviate symptoms and improve mobility in patients with knee OA.
Active Ingredients
In comparing Supartz vs Synvisc, it’s clear that while both viscosupplements use hyaluronic acid (HA) to relieve knee osteoarthritis symptoms, they differ in the source and composition of HA. These differences impact each product’s effectiveness and duration.
Supartz sources its hyaluronic acid from purified chicken combs to create a high molecular weight HA, formulated for safe and effective symptom relief in knee OA. Additional ingredients include:
- Sodium Chloride
- Dibasic Sodium Phosphate Dodecahydrate
- Sodium Dihydrogen Phosphate Dihydrate
- Water for Injection
On the other hand, Synvisc uses hylan polymers—chemically modified HA derivatives that raise its molecular weight and viscosity. Combining hylan A and hylan B creates a gel-like fluid that closely replicates the natural synovial fluid. Synvisc also contains:
- Sodium Chloride
- Disodium Hydrogen Phosphate
- Sodium Dihydrogen Phosphate Hydrate
- Water for Injection
Mechanism of Action
Though their HA compositions differ, Supartz and Synvisc work similarly to manage knee osteoarthritis symptoms. Injected into the knee, they restore lubrication and cushioning to the joint, helping to reduce pain and inflammation. Their HA formulations mimic natural synovial fluid, delivering these benefits:
- Reduced joint pain and swelling
- Improved mobility and range of motion
- Enhanced quality of life for knee OA patients
Administration Protocols
When selecting between these viscosupplements, individuals should consider the treatment sessions. Both Supartz and Synvisc require intra-articular injection into the affected knee joint. Understanding the correct Synvisc and Supartz dosage, treatment schedule, and administration protocols can help patients and providers decide which treatment can fit their needs and goals.
- Supartz Dosage and Treatment Schedule: This injectable typically requires a full 2.5 mL for each knee. The usual treatment schedule involves a series of three to five injections weekly.
- Synvisc Dosage and Treatment Schedule: Synvisc requires a 2 mL injection for each knee, three weekly injections in a cycle. Alternatively, Synvisc One offers a single-injection treatment of a 6 mL viscosupplement into the affected knee joint.
Medical providers should perform these procedures under sterile conditions to minimize infection risk. Furthermore, they should know the most appropriate injection technique to maximize the benefits of Supartz and Synvisc.
While effective in their protocols, Supartz and Synvisc differ in their recommended administration sessions. Supartz necessitates three to five weekly injections. In contrast, Synvisc generally involves three weekly or single Synvisc-One injections.
Effectiveness and Patient Experiences
A clinical study on Supartz demonstrated its efficacy in significantly relieving osteoarthritis pain. This benefit persisted for up to six months in a multicenter, randomized, placebo-controlled study involving 240 patients with knee osteoarthritis. The study also highlights the improvements in multiple clinical parameters, such as knee pain and stiffness.
In contrast, Synvisc provides both a single-shot treatment and multiple injections for knee osteoarthritis. Kearey et al. (2017) demonstrated that Synvisc’s single injection significantly improves knee OA pain. In clinical trials comparing Synvisc to saline, patients treated with Synvisc experienced an average reduction in weight-bearing pain of 48.8%, compared to 25% for those treated with saline.
According to WebMD, Supartz patients rated the injectable with an average of 3.4 stars out of 5, while Synvisc received 3 out of 5 stars. These few patients achieved substantial pain relief and enhanced mobility with their respective Supartz and Synvisc treatments.
Choosing the Right Viscosupplement
When deciding between Supartz and Synvisc for knee osteoarthritis, key factors include the patient’s medical history, severity of OA, and preference for injection frequency. Supartz requires a series of three to five weekly injections, while Synvisc offers the convenience of a single-injection option through Synvisc One.
Both Supartz and Synvisc primarily treat mild to moderate knee OA and are administered gradually for sustained relief. In contrast, some practitioners may also compare Supartz vs Euflexxa, another viscosupplement with a similar multi-injection protocol, for patients who may not respond as well to single-injection options like Synvisc One.
Ultimately, consulting with a healthcare provider ensures a tailored treatment plan that accounts for individual health factors and potential contraindications. A thorough assessment helps providers recommend the most suitable viscosupplement, maximizing both efficacy and safety and supporting optimal treatment outcomes.
Conclusion
Both Supartz and Synvisc can be effective options for managing knee osteoarthritis, though their ingredients and dosing schedules vary, which might make one a better fit over the other depending on individual needs. Knowing these differences can help patients make the best choice alongside their doctors.
Since results can vary from person to person, it’s vital to have a detailed conversation with a healthcare provider when deciding between Supartz and Synvisc. A personalized approach ensures each patient gets the most out of these treatments for knee osteoarthritis.
FAQs
1. What are Supartz and Synvisc?
Supartz and Synvisc are viscosupplements used to treat knee osteoarthritis. They contain hyaluronic acid, which helps lubricate and cushion the joint, reducing pain and improving mobility.
2. How do Supartz and Synvisc differ in their composition?
Supartz is derived from chicken combs and contains high molecular weight hyaluronic acid. In contrast, Synvisc uses chemically modified hylan polymers to enhance viscosity and mimic natural synovial fluid.
3. What are the administration protocols for Supartz and Synvisc?
Supartz typically requires a series of three to five 2.5 mL injections weekly. Synvisc usually involves three 2 mL injections weekly, though Synvisc One offers a single 6 mL injection as an alternative.
References
- World Health Organization. (2023, July 14). Osteoarthritis. Www.who.int; World Health Organization. https://www.who.int/news-room/fact-sheets/detail/osteoarthritis
- Science-driven Results – Bioventus OA Knee Pain Relief. (n.d.). Bioventus OA Knee Pain Relief. Retrieved October 30, 2024, from https://www.oakneepainrelief.com/supartz_fx/science-driven-results/
- Kearey, P., Popple, A. E., Warren, J., Davis, T., Bellamy, N., & LOBRAS Study Group (2017). Improvement in condition-specific and generic quality of life outcomes in patients with knee osteoarthritis following single-injection Synvisc: results from the LOBRAS study. Current medical research and opinion, 33(3), 409–419. https://doi.org/10.1080/03007995.2016.1260533
